Frontiers in Cardiovascular Medicine

JANUARY 2, 2024

Bicuspid aortic valve (BAV) is a common congenital heart condition that can lead to some valve-related complications, such as aortic stenosis and/or regurgitation, and is often associated with aortic root dilation.

Aortic valve 64

Aortic valve Bicuspid/Mitral Aortic Outcomes 64

Circulation: Cardiovascular Interventions

MARCH 4, 2024

BACKGROUND:Transcatheter edge-to-edge mitral valve (MV) repair (TEER) is an effective treatment for patients with primary mitral regurgitation at prohibitive risk for surgical MV repair (MVr). High-volume MVr centers and high-volume TEER centers have better outcomes than low-volume centers, respectively.

Bicuspid/Mitral 72

Bicuspid/Mitral Hospital Outcomes Heart Failure 72

DAIC

MARCH 18, 2024

a developer of innovative surgical robotic technologies dedicated to making world class robotic surgery affordable and accessible to a global population, today announced that surgeons have successfully performed the world’s first mitral valve replacement using the Made in India, SSi Mantra Surgical Robotic System. from 2022 to 2031.

Innovation 105

Innovation Bicuspid/Mitral Exercise Technology 105

DAIC

SEPTEMBER 4, 2024

1, 2024 — Researchers at UTHealth Houston have identified genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications. tim.hodson Wed, 09/04/2024 - 15:53 Sept.

Aortic valve 52

Aortic valve Bicuspid/Mitral Aortic Research 52

Frontiers in Cardiovascular Medicine

MARCH 20, 2025

ObjectivesRegistered, prospective, multicenter study of the short-term clinical outcomes of a novel transcatheter aortic valve system (Xcor system, Saint Medical Technology, Inc., Procedural, in-hospital, and follow-up clinical outcomes were evaluated after procedures.ResultsThe average age of the 130 patients was 71.24.4

Aortic valve 52

Aortic valve Aortic Bicuspid/Mitral Stenosis 52

The British Journal of Cardiology

MARCH 7, 2024

We assessed outcomes following mitral valvular surgery in a tertiary referral centre with a dedicated mitral multi-disciplinary team (MDT). This was a single-centre retrospective review of prospectively collected data within the ‘mitral database’ of mitral valvular disease patients.

Bicuspid/Mitral 52

Bicuspid/Mitral Outcomes Stenosis Hospital 52

American College of Cardiology

NOVEMBER 25, 2024

What are the procedural and clinical outcomes of balloon-expandable valves (BEVs) and self-expanding valves (SEVs) in Sievers type 1 bicuspid aortic valve (BAV) stenosis?

Bicuspid/Mitral 49

Bicuspid/Mitral Aortic valve Stenosis Aortic 49

American College of Cardiology

JANUARY 17, 2024

In patients with failed mitral valve prostheses, what are the clinical outcomes of redo surgical mitral valve replacement (SMVR) versus transcatheter mitral valve replacement (TMVR), and how does hospital case volume relate to outcomes?

Bicuspid/Mitral 67

Bicuspid/Mitral Hospital Outcomes Article 67

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

Background The clinical prognosis of mitral valve surgery at morning, afternoon, and evening is not yet clear. The aim of the study is to investigate the impact of different time periods of surgery in the morning, afternoon and evening on the short-term and long-term results of mitral valve surgery.

Bicuspid/Mitral 69

Bicuspid/Mitral Outcomes Aortic Hospital 69

American College of Cardiology

OCTOBER 30, 2024

Several abstracts presented at TCT 2024, taking place Oct.

Chest Pain 60

Chest Pain Coronary Artery Disease TAVR Bicuspid/Mitral 60

Journal of Cardiothoracic Surgery

MARCH 18, 2024

We investigated long-term outcomes, particularly later aorta operations and overall death in patients who underwent aortic valve replacement for bicuspid aortic valve without aortic surgery.

Aortic valve 52

Aortic valve Bicuspid/Mitral Aortic Outcomes 52

Circulation: Cardiovascular Interventions

OCTOBER 17, 2023

BACKGROUND:Data concerning the outcomes of transcatheter aortic valve replacement in type 0 bicuspid aortic stenosis (AS) are scarce. Ascending aortic diameter was the single predictor of 1-year mortality in type 0 bicuspid patients (hazard ratio, 1.59 [95% CI, 1.03–2.44];P=0.035). 2.44];P=0.035).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic Tricuspid 40

American College of Cardiology

OCTOBER 21, 2024

Patients with moderate or severe tricuspid regurgitation (TR) prior to undergoing TAVR or mitral transcatheter edge-to-edge repair (TEER), when compared to patients with no or mild TR, were associated with worse health status and clinical outcomes, according to a study published in JACC: Cardiovascular Interventions.

TAVR 53

TAVR Bicuspid/Mitral Outcomes Tricuspid 53

Frontiers in Cardiovascular Medicine

FEBRUARY 25, 2024

Background There are different types of transcatheter mitral valve repair (TMVr) currently in clinical use, including leaflet approximation, annular cinching, and restoration of the chordal apparatus of the mitral valve (MV). Aims To evaluate the procedural and clinical outcome of COMBO therapies compared with M-TEER alone.

Bicuspid/Mitral 59

Bicuspid/Mitral Outcomes Anatomy Heart Valves 59

Heart BMJ

AUGUST 14, 2024

Severe secondary mitral regurgitation carries a poor prognosis with one in five patients dying within 12 months of diagnosis. Fortunately, there are now a number of safe and effective therapies available to improve outcomes. Here, we summarise the most up-to-date treatments. to reduce heart failure hospitalisation and 5.9

Bicuspid/Mitral 59

Bicuspid/Mitral Atrial Fibrillation Heart Failure Outcomes 59

American College of Cardiology

NOVEMBER 13, 2024

In this week’s View, Dr. Eagle looks at contemporary outcomes and trends for the transseptal mitral valve-in-valve procedure using balloon-expandable transcatheter valves. He then explores complete vs. culprit-only revascularization in older patients with myocardial infarction (MI) with or without ST-segment elevation.

Bicuspid/Mitral 66

Bicuspid/Mitral Myocardial Infarction Hypertension Outcomes 66

Journal of Cardiothoracic Surgery

JULY 2, 2024

Although mitral valve repair is the preferred surgical strategy in children with mitral valve disease, there are cases of irreparable severe dysplastic valves that require mitral valve replacement. The aim of.

Bicuspid/Mitral 52

Bicuspid/Mitral Outcomes Research 52

Medical Xpress - Cardiology

AUGUST 19, 2024

Mitral regurgitation (MR) is a serious heart condition that often requires corrective surgery. It is characterized by the backflow or "regurgitation" of blood from the heart's left ventricle into the left atrium.

Bicuspid/Mitral 45

Bicuspid/Mitral Outcomes 45

Frontiers in Cardiovascular Medicine

JANUARY 25, 2024

Percutaneous balloon mitral valvotomy (PBMV) is a good and preferred therapy choice over surgical commissurotomy for patients with rheumatic mitral stenosis (MS). Conversely, AF leads to a lower PBMV success rate as well as worse long-term and in-hospital outcomes.

Bicuspid/Mitral 69

Bicuspid/Mitral Atrial Fibrillation Stenosis Arrhythmia 69

Journal of Cardiothoracic Surgery

JUNE 27, 2024

There is limited data on the 2-year outcomes of transapical transcatheter edge-to-edge repair (TA-TEER) using the ValveClamp in patients with severe primary mitral regurgitation (MR) and its impact on myocardi.

Bicuspid/Mitral 52

Bicuspid/Mitral Outcomes Research 52

Circulation: Cardiovascular Interventions

MARCH 20, 2025

BACKGROUND:Many patients with atrial functional mitral regurgitation are not suitable candidates for surgery or transcatheter repair. Procedural outcomes, 30-day survival, and echo findings are reported.RESULTS:Fourteen patients (71% women, mean age 77.9 There were no cases of left ventricular outflow tract obstruction.

Bicuspid/Mitral 40

Bicuspid/Mitral Atrial Fibrillation Anatomy Echocardiogram 40

American College of Cardiology

JANUARY 29, 2024

What are the long-term outcomes of mitral transcatheter edge-to-edge repair (M-TEER) compared to isolated mitral valve (MV) surgery among patients with severe mitral regurgitation (MR)?

Bicuspid/Mitral 53

Bicuspid/Mitral Outcomes Article 53

DAIC

MARCH 4, 2025

Early detection through regular heart check-ups, including listening for murmurs, can lead to timely treatment and improved outcomes. The earlier we catch it, the more treatment options we have, and the better the outcome for the patient. Many people with HVD may not experience symptoms until the disease reaches an advanced stage.

Heart Valves 52

Heart Valves Aortic valve Aortic Stenosis 52

American College of Cardiology

MARCH 28, 2024

What is the performance of an artificial intelligence (AI)-derived risk score in predicting 1-year outcomes of patients with secondary mitral regurgitation (SMR) undergoing transcatheter edge-to-edge repair (TEER)?

Bicuspid/Mitral 56

Bicuspid/Mitral Outcomes Article 56

DAIC

JUNE 11, 2024

Columbia University Irving Medical Center’s Division of Cardiology has announced its launch of the Mitral & Tricuspid Center. Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure.

Tricuspid 52

Tricuspid Bicuspid/Mitral Heart Valves Innovation 52

Heart BMJ

MAY 10, 2024

Objectives The association of pulmonary hypertension (PH) with the outcome after mitral transcatheter edge-to-edge repair (M-TEER) focusing on the new ESC/ERS guidelines definition for PH. Background PH is frequently found in patients with mitral regurgitation and is associated with lower survival rates.

Bicuspid/Mitral 52

Bicuspid/Mitral Pulmonary Hypertension Outcomes 52

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

Mitral valve prolapse (MVP) is a common condition that can lead to heart failure, arrhythmias, and even sudden death. Publicly available data from genome-wide association studies were used for both the exposures and outcomes. Currently, the role of immune cells in MVP is not well understood.

Bicuspid/Mitral 59

Bicuspid/Mitral Heart Valves Heart Failure Arrhythmia 59

Frontiers in Cardiovascular Medicine

JANUARY 25, 2024

On the contrary, the use of transcatheter edge-to-edge mitral valve repair (TEER) has exponentially increased over the past decade, expanding its potential use even in patients on the heart transplantation waiting list.

Bicuspid/Mitral 69

Bicuspid/Mitral Heart Failure Heart Transplant Transplant 69

Open Heart

JUNE 6, 2023

Objective Pulmonary hypertension (PHT) commonly coexists with significant mitral regurgitation (MR), but its prevalence and prognostic importance have not been well characterised. In a large cohort of adults with moderate or greater MR, we aimed to describe the prevalence and severity of PHT and assess its influence on outcomes.

Bicuspid/Mitral 52

Bicuspid/Mitral Pulmonary Hypertension Outcomes 52

Journal of Cardiothoracic Surgery

JANUARY 14, 2025

Transcatheter edge-to-edge repair (TEER) is an alternative for patients with severe degenerative mitral regurgitation (MR). The objective of this study was to compare the outcomes of surgery and TEER in older.

Bicuspid/Mitral 52

Bicuspid/Mitral Outcomes Research 52

Frontiers in Cardiovascular Medicine

OCTOBER 13, 2024

Background2020 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines state that the ideal time for mitral valve surgery in primary mitral regurgitation (PMR) is when the LV approaches but has not yet reached echocardiographic LV ejection fraction (EF)   40 mm.

Bicuspid/Mitral 52

Bicuspid/Mitral Blood Pressure Outcomes 52

Heart BMJ

DECEMBER 13, 2024

Secondary mitral regurgitation (SMR) is a complex and evolving challenge in the landscape of heart failure (HF) management. Although significant secondary MR has been widely recognised for its adverse outcomes, moderate SMR has historically been considered a more benign entity.

Pharmacology 52

Pharmacology Bicuspid/Mitral Heart Failure Outcomes 52

Circulation: Cardiovascular Interventions

JANUARY 18, 2024

BACKGROUND:Limited data exist regarding the impact of mitral annular calcification (MAC) on outcomes of transcatheter edge-to-edge repair for mitral regurgitation (MR).METHODS:We Circulation: Cardiovascular Interventions, Ahead of Print. with functional MR) who underwent an isolated, first-time intervention. versus 29.9%,P=0.060;

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Heart Failure Echocardiogram 40

Circulation: Cardiovascular Interventions

JUNE 10, 2024

We reported the feasibility and short-term outcomes of percutaneous transcatheter therapy with cerebral embolic protection. The indications for the transcatheter therapy were failed fibrinolysis, contraindications for fibrinolysis, not willing for fibrinolysis, or high risk for surgery. 1273.47) days, stroke was 1211.38 (95% CI, 1110.40–1312.35)

Embolism 40

Embolism Bicuspid/Mitral Outcomes Cardiovascular Interventions 40

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Outcomes were worse with increasing surgical urgency, older age, dialysis dependence, and multiple reoperations.

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundPrior studies investigating the impact of residual mitral regurgitation (MR), tricuspid regurgitation (TR), and elevated predischarge transmitral mean pressure gradient (TMPG) on outcomes after mitral transcatheter edge‐to‐edge repair (TEER) have assessed each parameter in isolation. 7.33],P=0.02).ConclusionsThe

Bicuspid/Mitral 40

Bicuspid/Mitral Outcomes Risk Factors Tricuspid 40

HeartRhythm

APRIL 30, 2024

High grade atrioventricular block requiring pacemaker (PPM) implantation is a common complication of mitral valve replacement (MVR) and is associated with longer hospital stays and higher readmission rates. These clinical outcomes have not been examined in large nationally representative cohorts.

Bicuspid/Mitral 40

Bicuspid/Mitral Pacemaker Outcomes Hospital 40